Vivimed Labs Ltd Falls 2.57% Amid Bearish Momentum and Volatile Trading

Monday, 10 August 2026: Stock Hits New 52-Week Low at Rs.4.83

Vivimed Labs Ltd’s share price plunged to a fresh 52-week low of Rs.4.83 on 10 August, marking a 4.55% decline on the day. This drop came despite the Sensex gaining 0.09%, highlighting the stock’s divergence from broader market trends. The fall to this level underscored persistent financial headwinds, including a negative EBITDA of Rs.-154.63 crore and a weak return on equity of 1.75%. The stock traded below all key moving averages, signalling sustained bearish momentum. The company’s micro-cap status and negative book value further weighed on investor sentiment.

Tuesday, 11 August 2026: All-Time Low at Rs.4.76 Followed by Upper Circuit Surge to Rs.5.12

The downward trend continued early on 11 August, with Vivimed Labs Ltd’s shares touching an all-time low of Rs.4.76, a steep fall of 5.14% over two days. This level represented an 82.42% decline from the 52-week high of Rs.27.99, reflecting the company’s prolonged underperformance. However, later in the session, the stock rebounded sharply, hitting the upper circuit limit at Rs.5.12, a 4.92% gain from the previous close. This surge was driven by strong buying interest and increased delivery volumes, suggesting a potential short-term reversal amid heightened market activity. Despite this, the stock remained below longer-term moving averages, indicating resistance to sustained recovery.

Wednesday, 12 August 2026: Price Retreats to Rs.5.07 on Heavy Volume

On 12 August, Vivimed Labs Ltd’s stock price retreated to Rs.5.07, down 1.74% from the previous close. The session saw a significant increase in trading volume, with 1.23 lakh shares changing hands, indicating active investor participation amid the ongoing volatility. The stock’s decline on this day aligned with a 0.17% drop in the Sensex, though the stock’s underperformance was more pronounced. Technical indicators remained bearish, with the stock trading below all major moving averages and exhibiting weak momentum.

Thursday, 13 August 2026: Further Decline to Rs.4.99 on Low Volume

The stock continued its downward trajectory on 13 August, closing at Rs.4.99, down 1.58%. Trading volume was notably lower at 9,297 shares, reflecting reduced investor activity. The Sensex, in contrast, gained 0.16%, underscoring the stock’s relative weakness. Technical signals remained bearish with no signs of immediate reversal. The stock’s position below all key moving averages and negative momentum indicators suggested continued pressure.

Friday, 14 August 2026: Week Ends at Rs.4.93, Down 1.20% on the Day

Vivimed Labs Ltd closed the week on 14 August at Rs.4.93, down 1.20% from the previous day’s close. The Sensex also declined by 0.17%, closing at 36,962.93. The stock’s weekly performance of -2.57% contrasted with the Sensex’s modest -0.37%, indicating underperformance. Despite the week’s volatility, the stock remained entrenched in a bearish trend, with fundamental challenges such as negative EBITDA, low profitability, and a high debt to EBITDA ratio continuing to weigh on sentiment.

Daily Price Comparison: Vivimed Labs Ltd vs Sensex

Key Takeaways from the Week

Persistent Downtrend: Vivimed Labs Ltd’s stock continued its bearish trajectory, hitting new 52-week and all-time lows early in the week. The stock’s weekly decline of 2.57% notably outpaced the Sensex’s 0.37% fall, reflecting company-specific challenges.

Volatility and Short-Term Rebound: The upper circuit hit on 11 August at Rs.5.12 indicated strong short-term buying interest and potential for volatility. However, this rally was not sustained, with the stock retreating in subsequent sessions.

Fundamental Weakness: The company’s negative EBITDA of Rs.-154.63 crore, low return on equity of 1.75%, and negative book value highlight ongoing financial stress. The high debt to EBITDA ratio of -2.61 times further signals limited debt servicing capacity.

Technical Indicators Bearish: The stock traded below all major moving averages throughout the week, with technical indicators such as MACD, RSI, and Bollinger Bands signalling bearish momentum on weekly and monthly scales.

Micro-Cap and Market Sentiment: Vivimed Labs Ltd’s micro-cap status and low institutional ownership contribute to volatility and subdued investor confidence. The MarketsMOJO Mojo Grade remains at Strong Sell with a score of 12.0, reflecting cautious market sentiment.

Conclusion

Vivimed Labs Ltd’s performance during the week of 10 to 14 August 2026 was characterised by continued weakness amid persistent financial and technical headwinds. Despite a brief surge to the upper circuit on 11 August, the stock closed the week lower, underperforming the broader market. The company’s negative earnings, poor profitability metrics, and bearish technical signals suggest ongoing challenges. Investors should note the stock’s micro-cap classification and strong sell rating, which underscore the elevated risk profile. The week’s events highlight the need for cautious monitoring of any future developments before considering a change in the stock’s trajectory.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today